口腔炎治療市場預測至2034年—按類型、藥物類別、劑型、適應症、給藥途徑、分銷管道、最終用戶和地區分類的全球分析

據 Stratistics MRC 稱，到 2026 年，全球口腔潰瘍治療市場規模將達到 19 億美元，預計在預測期內將以 5.9% 的複合年成長率成長，到 2034 年將達到 30 億美元。

口腔潰瘍，也常被稱為“復發性阿弗他潰瘍”，是指出現在舌頭、臉頰內側或嘴唇上的疼痛性潰瘍。它們通常會在一到兩週內自行癒合，但也有一些治療方法可以幫助緩解不適並加速癒合。此外，含有Benzocaine或水楊酸膽鹼的非處方外用軟膏和凝膠可以緩解疼痛。用鹽水漱口也有助於減輕發炎和促進癒合。

根據世界衛生組織2020年的報告，2020年全球約有22.30%的人口使用菸草製品，超過80%的全球菸草使用者生活在中低收入國家。吸煙會導致口腔潰瘍，從而增加對治療產品的需求。

提高對醫療保健的了解和獲取途徑

宣傳宣傳活動和資訊傳播提高了公眾對口腔健康的認知，促使人們轉變態度，更加重視及時就醫，解決口腔潰瘍等口腔健康問題。醫療服務的可近性不斷提高，包括完善的醫療基礎設施和遠端醫療服務，也增加了人們快速解決口腔健康問題的可能性。

缺乏標準化的治療指南

口腔炎治療缺乏標準化且廣泛認可的指南，導致治療方案有差異。臨床醫生可能採取不同的治療方法，這使得建立標準化的治療方案變得困難。此外，這種缺乏標準化的情況也可能使製藥業更難提供簡潔明了、科學有效的口腔炎治療方案。

人們對全面口腔健康的興趣日益濃厚

隨著人們越來越意識到口腔健康與整體健康之間的聯繫，口腔潰瘍治療市場有機會在更廣泛的綜合口腔清潔用品體系中佔有一席之地。此外，順應這一趨勢，可以將預防措施、飲食建議和生活方式提案納入治療方案，從而促進更全面、以患者為中心的治療方式。

景氣衰退和經濟負擔問題

經濟不穩定和景氣衰退會影響消費者在口腔潰瘍治療等醫療用品上的支出。經濟困難可能導致人們選擇更便宜的替代品或延遲治療。此外，市場參與企業應考慮定價策略、病患支援計畫和市場進入舉措，以減輕經濟挑戰的影響，並確保即使在經濟不確定時期也能持續獲得醫療服務。

新冠疫情的影響：

新冠肺炎疫情對口腔潰瘍治療市場造成了重大影響，原因在於生產、供應鏈和醫療服務取得管道的中斷。疫情導致的封鎖、社交距離措施以及醫療服務重點的調整，使得患者就診次數減少，進而影響了口腔潰瘍的診斷和治療。此外，消費者行為的改變和經濟的不確定性也影響了購買模式，這也可能對市場收入產生影響。

在預測期內，抗菌藥物細分市場預計將是規模最大的。

市佔率最大的細分市場是抗菌藥物細分市場。抗菌藥物，例如外用抗生素和消毒劑，對於治療口腔潰瘍至關重要，因為它們能夠預防或治療細菌和微生物引起的感染疾病。這些治療方法之所以經常被推薦，是因為它們著重於治療口腔潰瘍的感染表面，促進癒合，並緩解相關症狀。此外，抗菌藥物細分市場還包括局部製劑，例如凝膠、軟膏和漱口水，為醫療保健專業人員和消費者提供了多種有效治療口腔潰瘍的選擇。

在預測期內，家庭護理產業預計將呈現最高的複合年成長率。

在口腔潰瘍治療市場中，居家照護領域的複合年成長率最高。推動這一成長的因素包括：在家使用非處方口腔潰瘍治療藥物的便利性、自我治療的日益普及以及遠距遠端保健服務的發展，使得遠距諮詢成為可能。此外，口腔衛生意識的提高以及技術進步使得人們無需等待緊急臨床干預即可獲取治療口腔潰瘍的資訊和產品，這些都是推動居家護理市場發展的主要因素。

市佔率最大的地區：

亞太地區在口腔潰瘍治療市場佔最大佔有率。這一主導地位歸因於許多因素，包括該地區口腔潰瘍的高發病率、人口老化、口腔衛生意識的提高，以及製藥公司持續致力於拓展新興市場業務。此外，亞太地區多元化的醫療保健環境、不斷成長的可支配收入和日益完善的醫療基礎設施，也促進了口腔潰瘍治療市場的強勁成長。

複合年成長率最高的地區：

北美目前在口腔潰瘍治療市場中擁有最高的複合年成長率。完善的醫療保健基礎設施、高額的醫療費用支出以及對研發的高度重視是推動該地區強勁成長的主要因素。人口老化、口腔潰瘍發病率的上升以及該地區對口腔衛生日益成長的關注，都促使人們對先進且高效的治療方法的需求不斷成長。此外，行業領導者的存在、技術的進步以及積極主動的醫療保健管理方式也是推動北美市場擴張的重要因素。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

• 企業概況
  • 對其他市場參與者（最多 3 家公司）進行全面分析
  • 對主要公司進行SWOT分析（最多3家公司）
• 區域分類
  • 應客戶要求，我們提供主要國家和地區的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
• 競爭性標竿分析
  • 根據產品系列、地理覆蓋範圍和策略聯盟對重點公司進行基準分析。

目錄

第1章執行摘要

第2章：引言

• 概括
• 相關利益者
• 調查範圍
• 調查方法
• 研究材料

第3章 市場趨勢分析

• 促進因素
• 抑制因子
• 機會
• 威脅
• 最終用戶分析
• 新興市場
• 新冠疫情的感染疾病

第4章：波特五力分析

• 供應商的議價能力
• 買方的議價能力
• 替代品的威脅
• 新進入者的威脅
• 競爭公司之間的競爭

第5章 全球口腔潰瘍治療市場：按類型分類

• 溫和的
• 嚴重
• 皰疹
• 其他類型

第6章：全球口腔潰瘍治療市場：依藥物類別分類

• 抗菌劑
• 抗組織胺藥
• 止痛藥
• 皮質類固醇
• 其他藥物分類

第7章 全球口腔潰瘍治療市場：依劑型分類

• 噴
• 漱口水
• 凝膠
• 錠劑
• 其他劑型

第8章：全球口腔潰瘍治療市場：依適應症分類

• 復發性口瘡
• 口腔扁平苔癬
• 其他改編

第9章：全球口腔潰瘍治療市場：依給藥途徑分類

• 口服
• 外用

第10章 全球口腔潰瘍治療市場：依通路分類

• 醫院藥房
• 零售藥房
• 網路藥房

第11章 全球口腔潰瘍治療市場：依最終使用者分類

• 居家照護
• 診所
• 醫院
• 其他最終用戶

第12章 全球口腔潰瘍治療市場：按地區分類

• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 義大利
  • 法國
  • 西班牙
  • 其他歐洲國家
• 亞太地區
  • 日本
  • 中國
  • 印度
  • 澳洲
  • 紐西蘭
  • 韓國
  • 其他亞太國家
• 南美洲
  • 阿根廷
  • 巴西
  • 智利
  • 其他南美國家
• 中東和非洲
  • 沙烏地阿拉伯
  • UAE
  • 卡達
  • 南非
  • 其他中東和非洲國家

第13章 主要發展

• 合約、夥伴關係、合作關係、合資企業
• 收購與併購
• 新產品發布
• 業務拓展
• 其他關鍵策略

第14章：公司簡介

• Celgene Corporation
• 3M Company
• GSK plc
• Colgate-Palmolive Company
• Blairex Laboratories, Inc.
• Dr. Reddy's Laboratories
• Dental Herb Company
• Bristol-Myers Squibb Company
• GlaxoSmithKline, Plc
• Patterson Companies, Inc.
• Pfizer, Inc.
• Akorn Pharmaceuticals
• Church & Dwight Co, Inc.
• Prince Care Pharma Private Limited
• Blistex Inc.
• Sun Pharmaceutical Jsc

According to Stratistics MRC, the Global Mouth Ulcer Treatment Market is accounted for $1.9 billion in 2026 and is expected to reach $3.0 billion by 2034 growing at a CAGR of 5.9% during the forecast period. Mouth ulcers, commonly referred to as canker sores, are excruciating sores that may appear on the tongue, inside the cheeks, or on the lips. Although they usually go away on their own in a week or two, there are treatments that can help reduce discomfort and encourage quicker healing. Moreover, benzocaine or choline salicylate-containing over-the-counter topical ointments or gels can relieve pain. It might also be beneficial to rinse the mouth with a saltwater solution to lessen inflammation and encourage healing.

According to WHO 2020 report, in 2020, approximately 22.30% of the global population consumed tobacco products, and over 80% of the world's tobacco users live in low- and middle-income countries. Tobacco use can lead to mouth ulcers and thus the demand for treatment products increases.

Market Dynamics:

Driver:

Increasing knowledge and access to healthcare

An attitude shift toward seeking prompt medical attention for oral health issues, such as mouth ulcers, has resulted from increased awareness of oral health, which has been supported by educational campaigns and information dissemination. Individuals are more likely to address oral health concerns promptly when there is improved access to healthcare services, both in terms of physical infrastructure and telehealth options.

Restraint:

Absence of standardized guidelines for treatment

The lack of standardized and widely accepted treatment guidelines for mouth ulcers adds to the variation in medical procedures. Different approaches may be taken by clinicians, which make it difficult to establish standardized treatment protocols. Furthermore, this lack of standardization may make it more difficult for the industry to offer concise, scientifically supported mouth ulcer treatment options.

Opportunity:

Growing priority for comprehensive dental health

The market for mouth ulcer treatments has a chance to establish itself within the larger context of holistic oral care as people become more conscious of the link between oral health and general well-being. Moreover, preventive measures, dietary advice, and lifestyle suggestions can be incorporated into treatment plans to take advantage of this trend and promote a more thorough and patient-centered approach.

Threat:

Economic downturn and problems with affordability

Financial instability and economic downturns can affect how much consumers spend on medical supplies, such as mouth ulcer remedies. Financial difficulties can lead people to choose less expensive options or put off getting help. Additionally, market participants should investigate pricing strategies, patient assistance programs, and market access initiatives to ensure continued accessibility during times of economic instability in order to lessen the impact of economic challenges.

Covid-19 Impact:

Due to disruptions in manufacturing, supply chains, and healthcare access, the COVID-19 pandemic has had a major effect on the market for mouth ulcer treatments. The diagnosis and treatment of mouth ulcers have been impacted by the decline in routine healthcare visits brought on by lockdowns, social distancing measures, and the increased healthcare priorities associated with the pandemic. Furthermore, the market's revenue streams may also be impacted by changes in consumer behaviour and economic uncertainty, which have an impact on buying patterns.

The Antimicrobial segment is expected to be the largest during the forecast period

The segment with the largest market share is the antimicrobial segment, due to their ability to prevent or treat bacterial and microbial infections, antimicrobial agents-such as topical antibiotics and antiseptics-are essential in the management of mouth ulcers. Due to their focused approach to treating the infectious aspect of mouth ulcers, accelerating healing, and reducing related symptoms, these treatments are frequently encouraged. Moreover, healthcare practitioners and consumers have a variety of options for effectively managing mouth ulcers thanks to the antimicrobial segment's wide range of topical formulations, which include gels, ointments, and mouthwashes.

The Homecare segment is expected to have the highest CAGR during the forecast period

In the mouth ulcer treatment market, the homecare segment is growing at the highest CAGR. The convenience of using over-the-counter mouth ulcer treatments at home, the growing popularity of self-administered treatments, and the development of telehealth services that enable remote consultations are some of the factors contributing to this growth. Additionally, growing awareness of oral health management and technological advancements that make it possible for people to obtain information and products for treating mouth ulcers without waiting for urgent clinical intervention are the main drivers of the shift towards homecare.

Region with largest share:

In the mouth ulcer treatment market, the Asia-Pacific area holds the largest market share. Numerous factors contribute to this dominance, such as the high frequency of mouth ulcers in the area, an aging population, rising oral health awareness, and pharmaceutical companies' persistent efforts to increase their footprint in emerging markets. Furthermore, the diverse healthcare landscape of the Asia-Pacific region, along with rising disposable incomes and improved healthcare infrastructure, has also contributed to the market's robust growth for mouth ulcer treatments.

Region with highest CAGR:

In the mouth ulcer treatment market, North America is currently showing the highest CAGR. A strong healthcare infrastructure, high healthcare spending, and a strong emphasis on research and development are some of the factors driving the region's robust growth. The aging population in the area, the increasing frequency of mouth ulcers, and the increased focus on oral health all add to the rising need for cutting-edge and efficient treatment options. Moreover, the market is expanding in North America due in part to the presence of major players in the industry, technological advancements, and a proactive approach to healthcare management.

Key players in the market

Some of the key players in Mouth Ulcer Treatment market include Celgene Corporation, 3M Company, GSK plc, Colgate-Palmolive Company, Blairex Laboratories, Inc., Dr. Reddy's Laboratories, Dental Herb Company, Bristol-Myers Squibb Company, GlaxoSmithKline, Plc, Patterson Companies, Inc., Pfizer, Inc., Akorn Pharmaceuticals, Church & Dwight Co, Inc., Prince Care Pharma Private Limited, Blistex Inc. and Sun Pharmaceutical Jsc.

Key Developments:

In December 2023, Dr Reddy's Laboratories on Wednesday said its unit has inked a licensing agreement with Coya Therapeutics Inc to develop a combination therapy for the treatment of amyotrophic lateral sclerosis (ALS). Dr Reddy's Laboratories SA and Coya have entered into a development and license agreement for the development and commercialisation of COYA 302, an investigational combination therapy for ALS, the Hyderabad-based drugmaker said in a statement.

In November 2023, GSK plc and Arrowhead Pharmaceuticals Inc. have announced that they have reached an agreement with Janssen Pharmaceuticals, Inc., a Johnson & Johnson company, to transfer exclusive worldwide rights to further develop and commercialise JNJ-3989 to GSK. JNJ-3989 (formerly ARO-HBV) was initially in-licensed by Janssen from Arrowhead in 2018.

In May 2023, 3M announced it has entered into agreements to sell certain assets associated with its dental local anesthetic portfolio, based in Seefeld, Germany, to Pierrel S.p.A. ("Pierrel"), a global provider of services for the pharmaceutical industry, for a purchase price of $70 million, subject to closing and other adjustments.

Types Covered:

• Minor
• Major
• Herpetiform
• Other Types

Drug Classes Covered:

• Antimicrobial
• Antihistamine
• Analgesics
• Corticosteroids
• Other Drug Classes

Formulations Covered:

• Sprays
• Mouthwash
• Gels
• Lozenges
• Other Formulations

Indications Covered:

• Aphthous Stomatitis
• Oral Lichen Planus
• Other Indications

Route of Administrations Covered:

• Oral
• Topical

Distribution Channels Covered:

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

End Users Covered:

• Homecare
• Clinic
• Hospital
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 End User Analysis
• 3.7 Emerging Markets
• 3.8 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Mouth Ulcer Treatment Market, By Type

• 5.1 Introduction
• 5.2 Minor
• 5.3 Major
• 5.4 Herpetiform
• 5.5 Other Types

6 Global Mouth Ulcer Treatment Market, By Drug Class

• 6.1 Introduction
• 6.2 Antimicrobial
• 6.3 Antihistamine
• 6.4 Analgesics
• 6.5 Corticosteroids
• 6.6 Other Drug Classes

7 Global Mouth Ulcer Treatment Market, By Formulation

• 7.1 Introduction
• 7.2 Sprays
• 7.3 Mouthwash
• 7.4 Gels
• 7.5 Lozenges
• 7.6 Other Formulations

8 Global Mouth Ulcer Treatment Market, By Indication

• 8.1 Introduction
• 8.2 Aphthous Stomatitis
• 8.3 Oral Lichen Planus
• 8.4 Other Indications

9 Global Mouth Ulcer Treatment Market, By Route of Administration

• 9.1 Introduction
• 9.2 Oral
• 9.3 Topical

10 Global Mouth Ulcer Treatment Market, By Distribution Channel

• 10.1 Introduction
• 10.2 Hospital Pharmacy
• 10.3 Retail Pharmacy
• 10.4 Online Pharmacy

11 Global Mouth Ulcer Treatment Market, By End User

• 11.1 Introduction
• 11.2 Homecare
• 11.3 Clinic
• 11.4 Hospital
• 11.5 Other End Users

12 Global Mouth Ulcer Treatment Market, By Geography

• 12.1 Introduction
• 12.2 North America
  • 12.2.1 US
  • 12.2.2 Canada
  • 12.2.3 Mexico
• 12.3 Europe
  • 12.3.1 Germany
  • 12.3.2 UK
  • 12.3.3 Italy
  • 12.3.4 France
  • 12.3.5 Spain
  • 12.3.6 Rest of Europe
• 12.4 Asia Pacific
  • 12.4.1 Japan
  • 12.4.2 China
  • 12.4.3 India
  • 12.4.4 Australia
  • 12.4.5 New Zealand
  • 12.4.6 South Korea
  • 12.4.7 Rest of Asia Pacific
• 12.5 South America
  • 12.5.1 Argentina
  • 12.5.2 Brazil
  • 12.5.3 Chile
  • 12.5.4 Rest of South America
• 12.6 Middle East & Africa
  • 12.6.1 Saudi Arabia
  • 12.6.2 UAE
  • 12.6.3 Qatar
  • 12.6.4 South Africa
  • 12.6.5 Rest of Middle East & Africa

13 Key Developments

• 13.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 13.2 Acquisitions & Mergers
• 13.3 New Product Launch
• 13.4 Expansions
• 13.5 Other Key Strategies

14 Company Profiling

• 14.1 Celgene Corporation
• 14.2 3M Company
• 14.3 GSK plc
• 14.4 Colgate-Palmolive Company
• 14.5 Blairex Laboratories, Inc.
• 14.6 Dr. Reddy's Laboratories
• 14.7 Dental Herb Company
• 14.8 Bristol-Myers Squibb Company
• 14.9 GlaxoSmithKline, Plc
• 14.10 Patterson Companies, Inc.
• 14.11 Pfizer, Inc.
• 14.12 Akorn Pharmaceuticals
• 14.13 Church & Dwight Co, Inc.
• 14.14 Prince Care Pharma Private Limited
• 14.15 Blistex Inc.
• 14.16 Sun Pharmaceutical Jsc

List of Tables

• Table 1 Global Mouth Ulcer Treatment Market Outlook, By Region (2023-2034) ($MN)
• Table 2 Global Mouth Ulcer Treatment Market Outlook, By Type (2023-2034) ($MN)
• Table 3 Global Mouth Ulcer Treatment Market Outlook, By Minor (2023-2034) ($MN)
• Table 4 Global Mouth Ulcer Treatment Market Outlook, By Major (2023-2034) ($MN)
• Table 5 Global Mouth Ulcer Treatment Market Outlook, By Herpetiform (2023-2034) ($MN)
• Table 6 Global Mouth Ulcer Treatment Market Outlook, By Other Types (2023-2034) ($MN)
• Table 7 Global Mouth Ulcer Treatment Market Outlook, By Drug Class (2023-2034) ($MN)
• Table 8 Global Mouth Ulcer Treatment Market Outlook, By Antimicrobial (2023-2034) ($MN)
• Table 9 Global Mouth Ulcer Treatment Market Outlook, By Antihistamine (2023-2034) ($MN)
• Table 10 Global Mouth Ulcer Treatment Market Outlook, By Analgesics (2023-2034) ($MN)
• Table 11 Global Mouth Ulcer Treatment Market Outlook, By Corticosteroids (2023-2034) ($MN)
• Table 12 Global Mouth Ulcer Treatment Market Outlook, By Other Drug Classes (2023-2034) ($MN)
• Table 13 Global Mouth Ulcer Treatment Market Outlook, By Formulation (2023-2034) ($MN)
• Table 14 Global Mouth Ulcer Treatment Market Outlook, By Sprays (2023-2034) ($MN)
• Table 15 Global Mouth Ulcer Treatment Market Outlook, By Mouthwash (2023-2034) ($MN)
• Table 16 Global Mouth Ulcer Treatment Market Outlook, By Gels (2023-2034) ($MN)
• Table 17 Global Mouth Ulcer Treatment Market Outlook, By Lozenges (2023-2034) ($MN)
• Table 18 Global Mouth Ulcer Treatment Market Outlook, By Other Formulations (2023-2034) ($MN)
• Table 19 Global Mouth Ulcer Treatment Market Outlook, By Indication (2023-2034) ($MN)
• Table 20 Global Mouth Ulcer Treatment Market Outlook, By Aphthous Stomatitis (2023-2034) ($MN)
• Table 21 Global Mouth Ulcer Treatment Market Outlook, By Oral Lichen Planus (2023-2034) ($MN)
• Table 22 Global Mouth Ulcer Treatment Market Outlook, By Other Indications (2023-2034) ($MN)
• Table 23 Global Mouth Ulcer Treatment Market Outlook, By Route of Administration (2023-2034) ($MN)
• Table 24 Global Mouth Ulcer Treatment Market Outlook, By Oral (2023-2034) ($MN)
• Table 25 Global Mouth Ulcer Treatment Market Outlook, By Topical (2023-2034) ($MN)
• Table 26 Global Mouth Ulcer Treatment Market Outlook, By Distribution Channel (2023-2034) ($MN)
• Table 27 Global Mouth Ulcer Treatment Market Outlook, By Hospital Pharmacy (2023-2034) ($MN)
• Table 28 Global Mouth Ulcer Treatment Market Outlook, By Retail Pharmacy (2023-2034) ($MN)
• Table 29 Global Mouth Ulcer Treatment Market Outlook, By Online Pharmacy (2023-2034) ($MN)
• Table 30 Global Mouth Ulcer Treatment Market Outlook, By End User (2023-2034) ($MN)
• Table 31 Global Mouth Ulcer Treatment Market Outlook, By Homecare (2023-2034) ($MN)
• Table 32 Global Mouth Ulcer Treatment Market Outlook, By Clinic (2023-2034) ($MN)
• Table 33 Global Mouth Ulcer Treatment Market Outlook, By Hospital (2023-2034) ($MN)
• Table 34 Global Mouth Ulcer Treatment Market Outlook, By Other End Users (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.